Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Bos

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular and Cellular Endocrinology|June 1, 1976
Hormonal control of vitellogenin synthesis in avian liverM Gruber, E S Bos, G Ab
Immunologic Research|January 1, 1992
Immunotherapy through the IL-2 receptorH A Verheul, M Verveld, E S Bos
Bioconjugate Chemistry|May 1, 1995
Electrophoretic method for the quantitative determination of a benzyl-DTPA ligand in DTPA monoclonal antibody conjugatesD T Pham, F M Kaspersen, E S Bos
FEBS Letters|August 1, 1972
Lipovitellin synthesizing polysomes: Specific and quantitative isolationE S. Bos, R J. Vonk, M Gruber, et al.
European Journal of Pharmacology|January 1, 1970
Hepatic transport of mono bisquaternary ammonium compoundsD K Meijer, E S Bos, K J van der Laan
Journal of Immunoassay|January 1, 1981
3,3',5,5' - Tetramethylbenzidine as an Ames test negative chromogen for horse-radish peroxidase in enzyme-immunoassayE S Bos, A A van der Doelen, N van Rooy, et al.
Bioconjugate Chemistry|January 1, 1993
Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancerW H Kuijpers, E S Bos, F M Kaspersen, et al.
Bioconjugate Chemistry|July 20, 1999
Conjugation, immunoreactivity, and immunogenicity of calix[4]arenes; model study to potential calix[4]arene-based Ac3+ chelatorsM H Grote Gansey, A S de Haan, E S Bos, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 7, 1983
A novel assay for the quantitative determination of lipoprotein-X (LP-X) in serumE S Bos, A A van der Doelen, A E Denissen, et al.
Diabetes, Obesity & Metabolism|May 2, 2015
Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharideS Patterson, M de Kort, N Irwin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular and Cellular Endocrinology|June 1, 1976
Hormonal control of vitellogenin synthesis in avian liverM Gruber, E S Bos, G Ab
Immunologic Research|January 1, 1992
Immunotherapy through the IL-2 receptorH A Verheul, M Verveld, E S Bos
Bioconjugate Chemistry|May 1, 1995
Electrophoretic method for the quantitative determination of a benzyl-DTPA ligand in DTPA monoclonal antibody conjugatesD T Pham, F M Kaspersen, E S Bos
FEBS Letters|August 1, 1972
Lipovitellin synthesizing polysomes: Specific and quantitative isolationE S. Bos, R J. Vonk, M Gruber, et al.
European Journal of Pharmacology|January 1, 1970
Hepatic transport of mono bisquaternary ammonium compoundsD K Meijer, E S Bos, K J van der Laan
Journal of Immunoassay|January 1, 1981
3,3',5,5' - Tetramethylbenzidine as an Ames test negative chromogen for horse-radish peroxidase in enzyme-immunoassayE S Bos, A A van der Doelen, N van Rooy, et al.
Bioconjugate Chemistry|January 1, 1993
Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancerW H Kuijpers, E S Bos, F M Kaspersen, et al.
Bioconjugate Chemistry|July 20, 1999
Conjugation, immunoreactivity, and immunogenicity of calix[4]arenes; model study to potential calix[4]arene-based Ac3+ chelatorsM H Grote Gansey, A S de Haan, E S Bos, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 7, 1983
A novel assay for the quantitative determination of lipoprotein-X (LP-X) in serumE S Bos, A A van der Doelen, A E Denissen, et al.
Diabetes, Obesity & Metabolism|May 2, 2015
Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharideS Patterson, M de Kort, N Irwin, et al.
Pageof 2